
Study provides new insight on isolating and suppressing immune cells that could play a vital role in inhibiting other immunotherapy efforts against cancer.

Study provides new insight on isolating and suppressing immune cells that could play a vital role in inhibiting other immunotherapy efforts against cancer.

The prevalence of mumps in the state is reinvigorating the question about whether a third dose of measles, mumps and rubella vaccination is warranted.

Saliva-based testing may be just as effective as serum in assessing antibodies against infections like community-acquired pneumonia, according to a new UK study.

Researchers and physicians are working together to discover why adults skip recommended vaccines and what doctors can do to increase immunization rates.

Lead researcher hopes results of new study motivates more adults to improve vaccination compliance.

A new vaccine against Alzheimer’s targets two proteins involved in the development of the disease in hopes to offer both early and late protection.

Scientists at Emory University have developed a vaccine they say may work well in preventing infection with rhinovirus-the top cause of the common cold.

Practices that scrutinize vaccine costs and plan ahead may not make much off of vaccinations, but could cut some of their losses.

The CDC reaffirms its decision to pull the intranasal vaccine, but allow vaccination in egg-allergic individuals.

More susceptible to community-acquired pneumonia, researchers advise those with celiac disease to get vaccinated.

New research confirms that humans can make antibodies to neutralize several strains of influenza A, according to new study.

A practice’s immunization program requires constant attention and oversight. Here are seven best practices to consider.

Keep patients-and your practice’s bottom line-healthy with these suggestions for a successful immunization program.

Learn from one practice’s innovative approach to successful vaccine management to improve patient care.

A Canadian team is moving forward in advanced animal trials to test what could be the first successful vaccine against chlamydia.

Traditional pneumococcal vaccines can fight up to 23 of the most dangerous strains of pneumococcus, but a new vaccine may be able to fight all 90 strains.

Scientists at Oregon Health & Science University have found a way to reprogram immune cells to recognize and attack early HIV infection.

Telling stories about people like them, or reminding them of a previous illness may be the best thing physicians can do to nudge patients toward flu shots.

Researchers are testing a new type of immunization, using a bacterium found in soil, to help trigger the body’s defenses vs. stress and psychiatric disorders.

A new study reveals that Google can also show places where mandatory vaccination is in place to reduce preventable diseases.

A substance gleaned from the shells of crustaceans may hold the key to harnessing the power of the immune system to create new vaccines against diseases.

Time of day may be the key to improve vaccine efficacy, particularly in populations with poor immune responses according to a new report.

A lung cancer vaccine reportedly costing around $1 in Cuba that more than doubles life expectancies is on its way to clinical trials in the U.S.

A new report alleges that commercial plans provide better coverage than Medicare when it comes to vaccinations.

UC San Diego researchers are testing a new vaccine that they think could help prevent Alzheimer’s disease.